AXGN · Axogen, Inc.
$48.73
+0.68 (+1.42%)
At close · Aug 14
Market Cap
$2.62B
Shares
53.76M
Axogen, Inc. Earnings Call Transcripts
Every quarterly earnings call for Axogen, Inc. (AXGN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲18.4%
$36.96M
−$4.32M
'22 Q3
22-11-08
▲14.7%
$36.16M
−$5.42M
'22 Q4
23-01-09
▲18.2%
$36.66M
−$7.07M
'23 Q1
23-05-09
▲10.7%
$38.16M
−$6.66M
'23 Q2
23-08-07
▲11.7%
$41.27M
−$4.09M
'23 Q3
23-11-07
▲18.7%
$42.92M
−$3.89M
'23 Q4
24-03-05
▲12.9%
$41.38M
−$6.63M
'24 Q1
24-05-02
▲25.6%
$47.91M
−$1.92M
'24 Q2
24-08-08
▲17.9%
$48.64M
−$1.86M
'24 Q3
24-11-07
▲15.1%
$49.40M
$450,000
'24 Q4
25-01-10
▲17.4%
$48.56M
−$3.83M
'25 Q1
25-05-08
▲18.3%
$56.66M
$579,000
'25 Q2
25-08-05
▲23.5%
$60.08M
$708,000
'25 Q3
25-10-29
▲21.3%
$59.90M
−$13.16M
'25 Q4
26-02-24
▲26.6%
$61.46M
−$19.58M
'26 Q1
26-04-28
LATEST
▲23.1%
$69.73M
−$1.52M
'26 Q2
26-07-29
Earnings call
FY26 · Q2
2026-07-29
Second Quarter 2026 Financial Results Conference Call
Confident tone
Breast market development
Revenue growth and financial performance
Extremities, OMF and head and neck
Revenue
$69.73M
▲ 23.1% YoY Diluted EPS
$-0.03
▼ 400% YoY Gross margin
72.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-28
Axogen, Inc. Q1 FY2026 Earnings Call
Confident tone
Revenue growth and financial performance
Salesforce expansion and productivity
BLA transition and gross margin
Revenue
$61.46M
▲ 26.6% YoY Diluted EPS
$-0.38
Gross margin
75.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Axogen, Inc. Q4 FY2025 Earnings Call
Confident tone
Revenue growth and financial performance
2026 guidance and gross margin outlook
Breast market development
Revenue
$59.90M*
▲ 21.3% YoY Gross margin
74.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-29
Axogen, Inc. Q3 FY2025 Earnings Call
Confident tone
Avance Nerve Graft BLA approval
Revenue growth and market expansion
High potential accounts strategy
Revenue
$60.08M
▲ 23.5% YoY Diluted EPS
$0.01
Gross margin
76.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Axogen, Inc. Q2 FY2025 Earnings Call
Confident tone
Revenue growth and broad market adoption
BLA for Avance Nerve Graft
Gross margin and product costs
Revenue
$56.66M
▲ 18.3% YoY Diluted EPS
$0.01
Gross margin
74.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Axogen, Inc. Q1 FY2025 Earnings Call
Confident tone
BLA approval process for Avance Nerve Graft
Guidance and financial outlook
Professional education and surgeon training
Revenue
$48.56M
▲ 17.4% YoY Diluted EPS
$-0.08
Gross margin
71.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-10
Axogen, Inc. Q4 FY2024 Earnings Call
Positive tone
Revenue growth and guidance
Breast reconstruction / Resensation
Extremities market
Revenue
$49.40M*
▲ 15.1% YoY Gross margin
76.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Axogen, Inc. Q3 FY2024 Earnings Call
Positive tone
Revenue and EBITDA growth
BLA submission and Avance regulatory
New CEO strategic plan
Revenue
$48.64M
▲ 17.9% YoY Diluted EPS
$-0.04
Gross margin
74.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Axogen, Inc. Q2 FY2024 Earnings Call
Confident tone
Revenue growth and quarterly results
Core accounts and sales force expansion
Avance Nerve Graft BLA submission
Revenue
$47.91M
▲ 25.6% YoY Diluted EPS
$-0.04
Gross margin
73.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Axogen, Inc. Q1 FY2024 Earnings Call
Confident tone
Quarterly revenue growth and guidance
Core accounts and sales force productivity
Site of care and ambulatory surgery centers
Revenue
$41.38M
▲ 12.9% YoY Diluted EPS
$-0.15
Gross margin
78.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-05
Axogen, Inc. Q4 FY2023 Earnings Call
Positive tone
Revenue Growth and Core Accounts
Product Innovation and Launches
BLA Submission for Avance Nerve Graft
Revenue
$42.92M*
▲ 18.7% YoY Gross margin
74.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Axogen, Inc. Q3 FY2023 Earnings Call
Revenue
$41.27M
▲ 11.7% YoY Diluted EPS
$-0.10
Gross margin
76.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Axogen, Inc. Q2 FY2023 Earnings Call
Revenue
$38.16M
▲ 10.7% YoY Diluted EPS
$-0.16
Gross margin
77.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Axogen, Inc. Q1 FY2023 Earnings Call
Revenue
$36.66M
▲ 18.2% YoY Diluted EPS
$-0.17
Gross margin
77.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Axogen, Inc. Q4 FY2022 Earnings Call
Revenue
$36.16M*
▲ 14.7% YoY Gross margin
67.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Axogen, Inc. Q3 FY2022 Earnings Call
Revenue
$36.96M
▲ 18.4% YoY Diluted EPS
$-0.10
Gross margin
83.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-18
Axogen, Inc. Q2 FY2022 Earnings Call
Revenue
$34.45M
▲ 2.6% YoY Diluted EPS
$-0.18
Gross margin
81.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Axogen, Inc. Q1 FY2022 Earnings Call
Revenue
$31.01M
▼ 0.1% YoY Diluted EPS
$-0.27
Gross margin
82.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
Axogen, Inc. Q4 FY2021 Earnings Call
Revenue
$31.54M*
▼ 2.9% YoY Gross margin
82.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Axogen, Inc. Q3 FY2021 Earnings Call
Revenue
$31.20M
▼ 6.7% YoY Diluted EPS
$-0.17
Gross margin
83.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Axogen, Inc. Q2 FY2021 Earnings Call
Revenue
$33.58M
▲ 51.8% YoY Diluted EPS
$-0.19
Gross margin
78.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Axogen, Inc. Q1 FY2021 Earnings Call
Revenue
$31.04M
▲ 27.9% YoY Diluted EPS
$-0.16
Gross margin
83.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-22
Axogen, Inc. Q4 FY2020 Earnings Call
Revenue
$32.49M
▲ 15.4% YoY Gross margin
83.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Axogen, Inc. Q3 FY2020 Earnings Call
Revenue
$33.43M
▲ 17% YoY Diluted EPS
$-0.04
Gross margin
83.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-01
Axogen, Inc. Q2 FY2020 Earnings Call
Revenue
$22.12M
▼ 17.2% YoY Diluted EPS
$-0.20
Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-23
Axogen, Inc. Q1 FY2020 Earnings Call
Revenue
$24.26M
▲ 4.2% YoY Gross margin
80.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-24
Axogen, Inc. Q4 FY2019 Earnings Call
Revenue
$28.16M
▲ 20.2% YoY Gross margin
82.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
805928
CUSIP
05463X106
13F (30d)
244 filings
240 filers
Visit website
Investor relations